These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15080563)

  • 1. Clinical trials and p-values, beware of the extremes.
    Cleophas TJ
    Clin Chem Lab Med; 2004 Mar; 42(3):300-4. PubMed ID: 15080563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The behavior of the P-value when the alternative hypothesis is true.
    Hung HM; O'Neill RT; Bauer P; Köhne K
    Biometrics; 1997 Mar; 53(1):11-22. PubMed ID: 9147587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal conditional error functions for the control of conditional power.
    Brannath W; Bauer P
    Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical reporting in randomized controlled trials from the dermatology literature: a review of 44 dermatology journals.
    McClean M; Silverberg JI
    Br J Dermatol; 2015 Jul; 173(1):172-83. PubMed ID: 25989239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trials: Renewed attention to the interpretation of the P values--review.
    Cleophas TJ
    Am J Ther; 2004; 11(4):317-22. PubMed ID: 15266226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
    Vickers AJ
    BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing the degrees of freedom in future group randomized trials: the df * method revisited.
    Murray DM; Blitstein JL; Hannan PJ; Shadish WR
    Eval Rev; 2012 Dec; 36(6):430-48. PubMed ID: 23640051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empirical shrinkage estimator for consistency assessment of treatment effects in multi-regional clinical trials.
    Quan H; Li M; Shih WJ; Ouyang SP; Chen J; Zhang J; Zhao PL
    Stat Med; 2013 May; 32(10):1691-706. PubMed ID: 22855311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two new covariate adjustment methods for non-inferiority assessment of binary clinical trials data.
    Hou Y; Ding V; Li K; Zhou XH
    J Biopharm Stat; 2011 Jan; 21(1):77-93. PubMed ID: 21191856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials.
    Yusuf S; Wittes J; Probstfield J; Tyroler HA
    JAMA; 1991 Jul; 266(1):93-8. PubMed ID: 2046134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Power and sample size.
    Case LD; Ambrosius WT
    Methods Mol Biol; 2007; 404():377-408. PubMed ID: 18450060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and evaluation of multiregional trials with heterogeneous treatment effect across regions.
    Chen CT; Hung HM; Hsiao CF
    J Biopharm Stat; 2012 Sep; 22(5):1037-50. PubMed ID: 22946948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Appraisal of the Carlisle-Stouffer-Fisher Method for Assessing Study Data Integrity and Fraud.
    Mascha EJ; Vetter TR; Pittet JF
    Anesth Analg; 2017 Oct; 125(4):1381-1385. PubMed ID: 28786843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical trial designs and clinical practice: are they compatible?
    Punt CJ
    Onkologie; 2003 Dec; 26(6):518-9. PubMed ID: 14709922
    [No Abstract]   [Full Text] [Related]  

  • 17. The value of information and optimal clinical trial design.
    Willan AR; Pinto EM
    Stat Med; 2005 Jun; 24(12):1791-806. PubMed ID: 15806619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive designs based on the truncated product method.
    Neuhäuser M; Bretz F
    BMC Med Res Methodol; 2005 Sep; 5():30. PubMed ID: 16171518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size estimation: an overview with applications to orthodontic clinical trial designs.
    Pandis N; Polychronopoulou A; Eliades T
    Am J Orthod Dentofacial Orthop; 2011 Oct; 140(4):e141-6. PubMed ID: 21967951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How many do I need? Basic principles of sample size estimation.
    Devane D; Begley CM; Clarke M
    J Adv Nurs; 2004 Aug; 47(3):297-302. PubMed ID: 15238124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.